Nvidia Invests in Generate Biomedicines, an AI-Driven Biotech Startup
Nvidia has invested $13 million through its venture capital arm NVentures into pre-revenue biotechnology company Generate Biomedicines (GENB), which uses artificial intelligence to develop drug molecules. While the investment is relatively small compared to Nvidia's financial position, it highlights a strategic interest in AI applications beyond traditional tech sectors.
Topics: AI in biotech Generate Biomedicines Nvidia venture capital